Inventor

FOLTZ IAN

CA53 patents

⚠️ This page may combine multiple inventors who share the name “FOLTZ IAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

FOLTZ IAN

AMGEN INC

TRAIL receptor-2 polypeptides and antibodies

ST2 antigen binding proteins

Fully human monoclonal antibodies to IL-13

GITR antigen binding proteins and methods of use thereof

ST2 antigen binding proteins

Methods of using an alpha-4-beta-7 heterodimer specific antagonist antibody

Fully human monoclonal antibodies to IL-13

Interleukin-21 mutein/ anti-PD-1 antibody conjugates

Anti-human TREM2 antibodies and uses thereof

ST2 antigen binding proteins

Anti-PD-1 antibodies and methods of treatment

ST2 antigen binding proteins

ST2 antigen binding proteins

AMGEN FREMONT INC

Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

Methods of treating arthritic conditions with antibodies to M-CSF

Antibodies against carbonic anhydrase IX (CA IX) tumor antigen

Anti-CD45RB antibodies

Methods of use for antibodies against parathyroid hormone

Antibodies directed to parathyroid hormone (PTH) and uses thereof

Binding proteins specific for human matriptase

Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

Antibodies to M-CSF

Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

Antibodies to M-CSF

WEBER RICHARD

Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

HSU HAILING

Alpha-4 beta-7 heterodimer specific antagonist antibody

Alpha-4-beta-7 heterodimer specific antagonist antibody

Alpha-4-beta-7 heterodimer specific antagonist antibody

Alpha-4-beta-7 heterodimer specific antagonist antibody

MEDIMMUNE LTD

Antibodies directed to ERBB2

Antibodies to ErbB2

Targeted binding agents against B7-H1

BEDIAN VAHE

Targeted antibodies directed to DLL4

Nucleic acid molecules encoding antibodies to M-CSF

FOLTZ IAN

Anti-hepcidin antibodies and methods of use

Method of treating a malignant tumor by administering antibodies directed to DLL4

WARNER LAMBERT CO

Antibodies to M-CSF

AMGEN FREMONT

Antibodies to M-CSF

LANDES GREGORY M

Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereof

FACHINI ROGER

Human FGF receptor and β-Klotho binding proteins

RINKENBERGER JULIE

Antibodies directed to αVβ6 and uses thereof

HU SHAW-FEN SYLVIA

Human antigen binding proteins that bind β-Klotho, FGF receptors and complexes thereof

LI YANG

Human antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptor

ASTRAZENECA AB

Targeted binding agents directed to PDGFR-alpha and uses thereof

MEDIMMUNE LLC

Nucleic acid molecule encoding target antibodies directed to DLL4